In conclusion, we have found that treatment of Gprc5a-knockout mice with the tobacco-specific carcinogen NNK increased the rate of lung adenocarcinoma development compared to the spontaneous rate in control mice. Here, GPRC5A is linked to lung adenocarcinoma.